AMETEK, Inc. (NYSE:AME) Given Average Rating of “Moderate Buy” by Brokerages

AMETEK, Inc. (NYSE:AMEGet Free Report) has been given an average rating of “Moderate Buy” by the thirteen brokerages that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $239.2727.

AME has been the topic of several research analyst reports. Oppenheimer lowered shares of AMETEK from an “outperform” rating to a “market perform” rating in a research report on Tuesday, January 27th. Barclays raised their price objective on shares of AMETEK from $210.00 to $220.00 and gave the company an “equal weight” rating in a research note on Wednesday. Robert W. Baird upped their target price on shares of AMETEK from $198.00 to $204.00 and gave the stock a “neutral” rating in a research report on Monday, November 3rd. Melius Research set a $235.00 target price on shares of AMETEK in a report on Monday, January 5th. Finally, DA Davidson reissued a “buy” rating and set a $240.00 price target on shares of AMETEK in a research note on Wednesday.

Check Out Our Latest Stock Analysis on AMETEK

Insider Buying and Selling at AMETEK

In related news, VP Thomas M. Montgomery sold 6,388 shares of the stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $205.05, for a total value of $1,309,859.40. Following the sale, the vice president directly owned 22,116 shares of the company’s stock, valued at approximately $4,534,885.80. This represents a 22.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas C. Marecic sold 14,310 shares of the firm’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the transaction, the insider owned 42,589 shares of the company’s stock, valued at $8,607,662.79. This trade represents a 25.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 137,088 shares of company stock valued at $27,212,340. Insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Plato Investment Management Ltd grew its holdings in AMETEK by 0.4% during the 4th quarter. Plato Investment Management Ltd now owns 10,751 shares of the technology company’s stock valued at $2,218,000 after buying an additional 47 shares during the last quarter. Allegiance Financial Group Advisory Services LLC lifted its position in shares of AMETEK by 4.0% in the fourth quarter. Allegiance Financial Group Advisory Services LLC now owns 1,254 shares of the technology company’s stock valued at $257,000 after acquiring an additional 48 shares in the last quarter. Washington Trust Advisors Inc. boosted its stake in shares of AMETEK by 6.3% during the fourth quarter. Washington Trust Advisors Inc. now owns 850 shares of the technology company’s stock valued at $175,000 after acquiring an additional 50 shares during the last quarter. Fort Washington Investment Advisors Inc. OH increased its position in AMETEK by 2.9% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,816 shares of the technology company’s stock worth $373,000 after purchasing an additional 51 shares in the last quarter. Finally, Parallel Advisors LLC increased its position in AMETEK by 2.0% during the 3rd quarter. Parallel Advisors LLC now owns 2,766 shares of the technology company’s stock worth $520,000 after purchasing an additional 53 shares in the last quarter. 87.43% of the stock is owned by hedge funds and other institutional investors.

AMETEK Price Performance

Shares of NYSE:AME opened at $227.73 on Thursday. AMETEK has a 52 week low of $145.02 and a 52 week high of $234.56. The company has a 50-day moving average price of $209.65 and a 200 day moving average price of $195.06. The company has a market cap of $52.42 billion, a P/E ratio of 35.58, a PEG ratio of 3.10 and a beta of 1.03. The company has a quick ratio of 0.72, a current ratio of 1.06 and a debt-to-equity ratio of 0.10.

AMETEK (NYSE:AMEGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, beating the consensus estimate of $1.94 by $0.07. AMETEK had a return on equity of 16.55% and a net margin of 20.00%.The business had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period last year, the firm earned $1.87 EPS. The company’s quarterly revenue was up 13.4% compared to the same quarter last year. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. Research analysts predict that AMETEK will post 7.15 earnings per share for the current year.

AMETEK Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Friday, December 5th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Friday, December 5th. AMETEK’s payout ratio is presently 19.56%.

More AMETEK News

Here are the key news stories impacting AMETEK this week:

  • Positive Sentiment: AMETEK reported record fourth-quarter and full-year 2025 results, with revenue up ~13.4% Y/Y and EPS beating consensus ($2.01 vs. $1.94). Strong top‑line growth and margin resilience underpin the bull case. AMETEK Announces Record Fourth Quarter and Full Year Results
  • Positive Sentiment: Analysts reacted with some upgrades: KeyCorp raised its price target to $260 (overweight) and DA Davidson reaffirmed a Buy at $240 — both signal upside from current levels and support the stock. Benzinga
  • Positive Sentiment: AMETEK announced the acquisition of LKC Technologies (ophthalmic diagnostics), adding a niche healthcare/medical device asset that diversifies revenue and enhances long‑term growth optionality. AMETEK Acquires LKC Technologies
  • Neutral Sentiment: The company hosted an earnings call and published transcripts; management reiterated a confident long‑term outlook while discussing drivers behind the record results — useful for modeling but not market‑moving by itself. Earnings Call Transcript
  • Neutral Sentiment: Coverage summaries and earnings recaps (Zacks, Globe and Mail, Seeking Alpha transcripts) confirm beats on EPS and revenue and provide detail for financial models. Zacks: AMETEK Q4 Earnings Surpass Expectations
  • Negative Sentiment: FY‑2026 guidance came in slightly below Street expectations for EPS (7.870–8.070 vs. ~8.00 consensus) and Q1 guidance was marginally light — this tempered enthusiasm after the beat. MarketBeat: AMETEK Earnings
  • Negative Sentiment: Management flagged tariff uncertainty and margin pressure in pockets of the business; analysts and commentary note acquisitions and niche expansion helped offset margin headwinds but risks remain. MSN: Q4 Deep Dive
  • Negative Sentiment: Some analysts remain cautious on valuation — Morgan Stanley maintained a Hold with a $215 target and independent commentary warns that high valuation could lead to downgrades if execution slips. That contributes to short‑term selling pressure. TipRanks: Hold Rating

About AMETEK

(Get Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Stories

Analyst Recommendations for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.